cvs glp 1 weight management program reports 50% of clients cover GLP-1s for loss | Bryce Platt, PharmD posted on the topic cvs glp 1 program CVS

GLP-1 induced nausea is one of the most frequently reported side effects of GLP-1 receptor agonist medications, including semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro)

One participant lost 22% of her weight in nine months substantially faster than the rate seen with approved GLP-1 drugs like Wegovy or Zepbound

[DOI] [PubMed] [Google Scholar] 662.Lovshin J.A., Barnie A., DeAlmeida A., Logan A., Zinman B., Drucker D.J

Sometimes if the new drug is easier to tolerate and its easier to stick with the treatment

states and ships medication directly

A longer duration of GLP-1 receptor agonist use was also associated with a lower risk of invasive mechanical ventilation, bacterial pneumonia, mortality, and cardiovascular events [35]